You are searching for: hsa04150

---

T20178 Target Info	Target Name	Tumor necrosis factor (TNF)
	Target type	Successful Target
	Disease	Intermittent claudication; Multiple myeloma;
	Drugs	Adalimumab	Drug Info

T99057 Target Info	Target Name	HUMAN ERK activator kinase 1 (MEK1)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T82841 Target Info	Target Name	Insulin (INS)
	Target type	Successful Target
	Disease	Measure kidney function; Malaria;
	Drugs	Insulin determir	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T70977 Target Info	Target Name	Glycogen synthase kinase-3 beta (GSK-3B)
	Target type	Clinical trial Target
	Disease	Myotonic dystrophy; Acute myeloid leukaemia;
	Drugs	AMO-02	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T58970 Target Info	Target Name	Extracellular signal-regulated kinase 2 (ERK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Artery stenosis;
	Drugs	BVD-523	Drug Info

T78429 Target Info	Target Name	Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
	Target type	Clinical trial Target
	Disease	Acute lymphoblastic leukaemia; Alzheimer disease;
	Drugs	Arsenic trioxide	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.